Date Filed | Type | Description |
10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2023 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 266,500 options to buy
@ $1.21, valued at
$322.5k
Granted 133,250 options to buy
@ $1.21, valued at
$161.2k
|
|
08/11/2023 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 99,400 options to buy
@ $1.21, valued at
$120.3k
Granted 49,700 options to buy
@ $1.21, valued at
$60.1k
|
|
08/11/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Radovich Peter (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Nguyen Tran (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Wolff Stefani (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Hrustanovic Gorjan (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Davis Aaron I. (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
08/11/2023 |
4
| Atkisson Erik (General Counsel and CCO) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 60,251 options to buy
@ $1.21, valued at
$72.9k
|
|
08/11/2023 |
4
| Bruce Josephine (Principal Fin. & Acc. Officer) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Granted 10,800 options to buy
@ $1.21, valued at
$13.1k
|
|
06/09/2023 |
3
| Bruce Josephine (Principal Fin. & Acc. Officer) has filed a Form 3 on Rain Oncology Inc. |
06/01/2023 |
4
| TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Bought 347,932 shares
@ $1.05, valued at
$365.3k
Bought 200,000 shares
@ $1, valued at
$200k
Bought 32,890 shares
@ $1.06, valued at
$34.9k
Bought 2,016 shares
@ $1.08, valued at
$2.2k
Bought 5,930 shares
@ $1.06, valued at
$6.3k
Bought 161,180 shares
@ $1.08, valued at
$174.1k
Bought 5,000 shares
@ $1.1, valued at
$5.5k
Bought 92,984 shares
@ $1.09, valued at
$101.4k
Bought 240,341 shares
@ $1.12, valued at
$269.2k
|
|
06/01/2023 |
3
| TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc. |
05/24/2023 |
4
| Boxer Capital, LLC (Director) has filed a Form 4 on Rain Oncology Inc.
Txns:
| Sold 995,000 shares
@ $1.25, valued at
$1.2M
|
|
11/23/2022 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Bought 45,000 shares
@ $7.8, valued at
$351k
Bought 77,000 shares
@ $8.27, valued at
$636.8k
|
|
11/08/2022 |
4
| Davis Aaron I. (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Bought 972,212 shares
@ $5.83, valued at
$5.7M
Bought 400,000 options to buy
@ $5.83, valued at
$2.3M
|
|
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Bought 25,000 shares
@ $2.29, valued at
$57.3k
|
|
04/15/2022 |
4
| Vellanki Avanish (Chairman and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Gifted 59,618 shares
@ $0 Gifted 59,618 shares
@ $0 |
|
04/15/2022 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Exercised 3,000 options to buy
@ $3.95, valued at
$11.9k
|
|
04/04/2022 |
4
| Doebele Robert (See Remarks) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Exercised 2,000 options to buy
@ $3.95, valued at
$7.9k
|
|
03/15/2022 |
4
| Vellanki Avanish (President and CEO) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Exercised 14,468 options to buy
@ $4, valued at
$57.9k
|
|
02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.
Txns:
| Bought 255,500 shares
@ $12, valued at
$3.1M
Bought 61,343 shares
@ $11.9984, valued at
$736k
Bought 226,079 shares
@ $12, valued at
$2.7M
Bought 14,806 shares
@ $12, valued at
$177.7k
|
|
|